Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events

Virupakshi Jalihal, Rohit Shankar*, William Henley, Mary Parrett, Phil Tittensor, Brendan N. McLean, Ammad Ahmed, Josemir W. Sander

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science